Screener
Bio-Rad Laboratories BIO Life Science — Goodwill, Period Increase (Decrease)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillPeriodIncreaseDecrease.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| Balances as of December 31, 2025 | Life Science | Clinical Diagnostics | Total |
|---|---|---|---|
| Accumulated impairment losses | (41.8) | (293.4) | (335.2) |
| Goodwill, net | 451.4 | 128.4 | 579.8 |
| Foreign currency adjustments | (2.7) | — | (2.7) |
| Period change, net | (2.7) | — | (2.7) |
| Balances as of March 31, 2026 | |||
| Goodwill | 490.5 | 421.8 | 912.3 |
| Accumulated impairment losses | (41.8) | (293.4) | (335.2) |
| Goodwill, net | $448.7 | $128.4 | $577.1 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's life science — goodwill, period increase (decrease)?
- Bio-Rad Laboratories (BIO) reported life science — goodwill, period increase (decrease) of -$2.7M in Q1 2026.
- What is the long-term trend for Bio-Rad Laboratories's life science — goodwill, period increase (decrease)?
- Over 3 years (2021 to 2025), Bio-Rad Laboratories's life science — goodwill, period increase (decrease) has grown at a 43.0% compound annual growth rate (CAGR), from $55.4M to $162.1M.
- What does life science — goodwill, period increase (decrease) mean?
- The net change in the goodwill balance for the Life Science segment during the reporting period. This includes new acquisitions, divestitures, and adjustments for impairment or currency translation.
Ask your AI about Bio-Rad Laboratories's life science — goodwill, period increase (decrease).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude